Please login to the form below

Not currently logged in
Email:
Password:

Banned Chinese medicine in the UK

More than 900 packs of a potentially dangerous traditional Chinese medicine are on the UK market despite warnings issued by the MHRA

More than 900 packs of a potentially dangerous traditional Chinese medicine (TCM) are currently on the UK market despite warnings issued by the Medicines and Healthcare products Regulatory Agency (MHRA).

The unlicensed herbal product - Jingzhi Kesou Tan Chuan Wan - was distributed to 20 TCM and herbal medicine outlets throughout the UK. A recall was initiated by the distributor, Ekong International, in February 2010, however, more than three quarters of the stock brought in from China has still not been returned.

It has been revealed that new labelling in English had been applied to packs to conceal the original label, which contained the Chinese symbols for Aristolochia, a banned toxic and carcinogenic plant derivative.

Exposure to aristolochic acids can result in kidney failure and the development of cancer, particularly of the urinary tract.

The MHRA has written to TCM trade and practitioner associations to ensure that none of their members are supplying the product.

29th March 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...

Infographics